With the widespread use of PSA screening tests, the incidence rates of prostate cancers have increased, and mortality rates have decreased, while the overdiagnosis and overtreatment of clinically insignificant cancers have also been controversial [20]. This evidence concerns the gene KLK3 and cancer.